FOXP3 and adenocarcinoma: Our data indicated that TOC significantly increased the TTP for dogs with adenocarcinomas, and decreased the number of intratumoral Foxp3+ Tregs and HIF‐1α+ tumor cells, as well as inhibited VEGFR2 expression.